{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:12:25Z","timestamp":1792156345654,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"The Norwegian Women's Public Health Association","award":["H1\/2014"],"award-info":[{"award-number":["H1\/2014"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.ygyno.2015.11.016","type":"journal-article","created":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T03:01:13Z","timestamp":1447815673000},"page":"101-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Sexual activity and functioning after risk-reducing salpingo-oophorectomy: Impact of hormone replacement therapy"],"prefix":"10.1016","volume":"140","author":[{"given":"Nora","family":"Johansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid H.","family":"Liavaag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom G.","family":"Tanbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alv A.","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Are H.","family":"Pripp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trond M.","family":"Michelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2015.11.016_bb0005","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.11.016_bb0010","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ygyno.2015.11.016_bb0015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation","volume":"296","author":"Finch","year":"2006","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ygyno.2015.11.016_bb0020","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/jmg.2008.058248","article-title":"Screening for familial ovarian cancer: poor survival of BRCA1\/2 related cancers","volume":"46","author":"Evans","year":"2009","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ygyno.2015.11.016_bb0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2015.11.016_bb0030","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ygyno.2015.11.016_bb0035","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12905-014-0150-5","article-title":"Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers","volume":"14","author":"Marchetti","year":"2014","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.ygyno.2015.11.016_bb0040","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1200\/JCO.2007.11.3449","article-title":"Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2","volume":"25","author":"Kauff","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.11.016_bb0045","series-title":"Breast and Ovarian. NCCN Clinical Practice Guidelines in Oncology","article-title":"Genetic\/familial high-risk assessment","author":"Daly","year":"2015"},{"key":"10.1016\/j.ygyno.2015.11.016_bb0050","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/gme.0b013e31824b970a","article-title":"The 2012 hormone therapy position statement of: the North American menopause society","volume":"19","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.ygyno.2015.11.016_bb0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/gme.0b013e318184c440","article-title":"A randomized study of low-dose conjugated estrogens on sexual function and quality of life in postmenopausal women","volume":"16","author":"Gast","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.ygyno.2015.11.016_bb0060","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1743-6109.2009.01629.x","article-title":"Endocrine aspects of women's sexual function","volume":"7","author":"Wierman","year":"2010","journal-title":"J. Sex Med."},{"key":"10.1016\/j.ygyno.2015.11.016_bb0065","series-title":"The Cochrane Database of Systematic Reviews.","first-page":"Cd004509","article-title":". Testosterone for peri- and postmenopausal women.","author":"Somboonporn","year":"2005"},{"key":"10.1016\/j.ygyno.2015.11.016_bb0070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ygyno.2010.12.326","article-title":"The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation","volume":"121","author":"Finch","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.11.016_bb0075","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1200\/JCO.2005.05.1896","article-title":"The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy","volume":"24","author":"Madalinska","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.11.016_bb0080","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00435972","article-title":"The sexual activity questionnaire: a measure of women's sexual functioning","volume":"5","author":"Thirlaway","year":"1996","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.ygyno.2015.11.016_bb0085","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2015.11.016_bb0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0959-8049(00)00353-1","article-title":"A body image scale for use with cancer patients","volume":"37","author":"Hopwood","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2015.11.016_bb0095","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.1200\/JCO.2005.02.626","article-title":"Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer","volume":"23","author":"Madalinska","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2015.11.016_bb0100","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ygyno.2007.10.009","article-title":"A controlled study of sexual activity and functioning in epithelial ovarian cancer survivors. A therapeutic approach","volume":"108","author":"Liavaag","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2015.11.016_bb0105","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/1403494810371245","article-title":"Sexual problems in 18\u201367-year-old Norwegians","volume":"38","author":"Traeen","year":"2010","journal-title":"Scand.J. Public Health"},{"key":"10.1016\/j.ygyno.2015.11.016_bb0110","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/13697130601167956","article-title":"Correlates of sexual functioning among mid-life women","volume":"10","author":"Gallicchio","year":"2007","journal-title":"Climact. J.e Int. Menopause Soc."},{"key":"10.1016\/j.ygyno.2015.11.016_bb0115","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1743-6109.2011.02634.x","article-title":"Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women","volume":"9","author":"Davis","year":"2012","journal-title":"J. Sex Med."},{"key":"10.1016\/j.ygyno.2015.11.016_bb0120","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/GME.0000000000000134","article-title":"Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial","volume":"21","author":"Simon","year":"2014","journal-title":"Menopause"},{"key":"10.1016\/j.ygyno.2015.11.016_bb0125","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/gme.0b013e3181cb49e9","article-title":"The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women","volume":"17","author":"Edlefsen","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.ygyno.2015.11.016_bb0130","series-title":"Discovering Statistics Using IBM SPSS Statistics","author":"Field","year":"2013"},{"key":"10.1016\/j.ygyno.2015.11.016_bb0135","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.ygyno.2015.11.016_bb0140","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/ijerph7010325","article-title":"To match or not to match in epidemiological studies\u2013same outcome but less power","volume":"7","author":"Faresjo","year":"2010","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.ygyno.2015.11.016_bb0145","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ygyno.2008.12.024","article-title":"A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer","volume":"113","author":"Michelsen","year":"2009","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815301906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825815301906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T08:39:09Z","timestamp":1653554349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825815301906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0090825815301906"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.11.016","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725957592.793527306","asserted-by":"object"}]},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sexual activity and functioning after risk-reducing salpingo-oophorectomy: Impact of hormone replacement therapy","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2015.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}